University of New Mexico Women's Care Clinic
Welcome,         Profile    Billing    Logout  
 1 Trial 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Komesu, Yuko M
SUPeR, NCT01802281: Study of Uterine Prolapse Procedures - Randomized Trial

Active, not recruiting
N/A
183
US
Uterosacral ligament suspension, Uphold® LITE
NICHD Pelvic Floor Disorders Network, Boston Scientific Corporation
Uterovaginal Prolapse
07/23
10/24
Lee, Una
CELLEBRATE, NCT03104517 / 2016-002635-15: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Recruiting
3
96
Europe, US
AMDC-USR (iltamiocel), Placebo
Cook MyoSite
Stress Urinary Incontinence
01/25
02/26
NCT04933084: Pre-operative Education Modalities to Decrease Opioid Use

Recruiting
N/A
60
US
Pre-operative Opioid Education
Benaroya Research Institute
Prostatectomy, Opioid-Related Disorders
05/24
05/24
TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study

Active, not recruiting
N/A
188
US
Medtronic Implantable Tibial Neuromodulation (TNM) System
MedtronicNeuro
Overactive Bladder
10/23
04/25
Livingston, Jeff
NCT04209543 / 2019-001289-14: Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Completed
3
1570
Europe, Canada, US, RoW
Estetrol, Placebo, Progesterone
Estetra, ICON Clinical Research
Vasomotor Symptoms, Menopausal Symptoms
02/24
02/24
CELLEBRATE, NCT03104517 / 2016-002635-15: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Recruiting
3
96
Europe, US
AMDC-USR (iltamiocel), Placebo
Cook MyoSite
Stress Urinary Incontinence
01/25
02/26
PVX-2, NCT03911076: Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

Terminated
2
16
US
PVX-2, Placebo
PapiVax Biotech, Inc., Parexel
ASC-US, ASC-H, LSIL
06/22
06/22
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25
PURSUIT, NCT04720352: Prospective US Radiofrequency SUI Trial

Recruiting
N/A
390
US
Active treatment, Sham
Viveve Inc.
Urinary Incontinence, Stress
12/22
12/22
Antosh, Danielle
CELLEBRATE, NCT03104517 / 2016-002635-15: Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Recruiting
3
96
Europe, US
AMDC-USR (iltamiocel), Placebo
Cook MyoSite
Stress Urinary Incontinence
01/25
02/26

Download Options